...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: It's Time For Zenith To Disclose

SF,

 

I share your frustration with the lack of info/details on the Zenith 3694 phase 1 trial,  I am purely speculation here, but perhap that there may be negotiations going between some pharma or a few in regards to deal and that perhaps details of the trial need to be kept secret until a deal is fianlized, We did have a cancellation of Zenith AGM which I can only imagine was for a very important reason......    Time will tell but I am crossing my fingers that management is finalizing a deal to be announced once completed...

Share
New Message
Please login to post a reply